[Vedolizumab in Crohn Disease genesis-sefh drug evaluation report]. (Record no. 25428481)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01377 a2200325 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517062434.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201701s 0 0 spa d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 2171-8695 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.7399/fh.2015.39.5.8981 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | González Chávez, Jenifer |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20170119 |
| 245 00 - TITLE STATEMENT | |
| Title | [Vedolizumab in Crohn Disease genesis-sefh drug evaluation report]. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria |
| Date of publication, distribution, etc. | Sep 2015 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 297-308 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies, Monoclonal, Humanized |
| General subdivision | economics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Crohn Disease |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Evaluation |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Immunosuppressive Agents |
| General subdivision | economics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Multicenter Studies as Topic |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Randomized Controlled Trials as Topic |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Asensi Diez, Rocio |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tamayo Bermejo, Rocío |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Alegre Del Rey, Emilio Jesús |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Martínez López de Castro, Noemí |
| 773 0# - HOST ITEM ENTRY | |
| Title | Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria |
| Related parts | vol. 39 |
| -- | no. 5 |
| -- | p. 297-308 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.7399/fh.2015.39.5.8981">https://doi.org/10.7399/fh.2015.39.5.8981</a> |
| Public note | Available from publisher's website |
No items available.